热门资讯> 正文
scPharmaceuticals宣布通过Perceptive Advisors提供高达1.25亿美元的非稀释性融资
2024-08-13 00:53
- scPharmaceuticals (NASDAQ:SCPH) on Monday announced non-dilutive financings totaling up to $125M with funds managed by Perceptive Advisors.
- Proceeds from the transactions will be used to repay existing debt, as well as to fund activities related to the ongoing commercialization of FUROSCIX.
- The company received $75M through a combination of debt and royalty financings at close, with access to an additional $50M.
- The term loan refinances existing debt principal; lowers coupon, extends interest-only period for four additional years, and lowers minimum cash requirement to $5M.
- Press release.
More on scPharmaceuticals
- scPharmaceuticals gets %125M funding from Perceptive Advisors
- Seeking Alpha’s Quant Rating on scPharmaceuticals
- Historical earnings data for scPharmaceuticals
- Financial information for scPharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
